Edition:
United States

Sienna Biopharmaceuticals Inc (SNNA.OQ)

SNNA.OQ on NASDAQ Stock Exchange Global Select Market

12.20USD
11:16am EDT
Change (% chg)

$0.95 (+8.44%)
Prev Close
$11.25
Open
$11.31
Day's High
$12.49
Day's Low
$11.31
Volume
4,630
Avg. Vol
20,827
52-wk High
$25.58
52-wk Low
$9.83

Select another date:

Mon, Jul 30 2018

Sienna Biopharma sinks after acne treatment fails two trials

Sienna Biopharmaceuticals Inc said its lead experimental acne treatment failed to meet the main goals of two pivotal trials and that the chances of it clearing a third study appeared weaker, sending its shares tumbling 19 percent.

UPDATE 2-Sienna Biopharma sinks after acne treatment fails two trials

* Shares hit record low (Adds details from conference call, updates share movement)

CORRECTED-UPDATE 1-Sienna Biopharma sinks after acne drug fails two trials

July 30 Sienna Biopharmaceuticals Inc said on Monday two pivotal trials testing its lead experimental treatment for acne did not meet their main goals, sending its shares tumbling nearly 28 percent before the bell.

Sienna Biopharmaceuticals' acne drug fails two trials

July 30 Sienna Biopharmaceuticals Inc said on Monday two pivotal trials testing its acne treatment did not meet their main goals of reducing inflammatory lesions on patients' skin.

BRIEF-Sienna Biopharmaceuticals Reports Qtrly Loss Per Share $0.85

* SIENNA BIOPHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Sebacia Announces Favorable Ruling By U.S. Court Regarding Patent Proceedings With Sienna Biopharma

* SEBACIA - ANNOUNCES FAVORABLE RULING BY U.S. FEDERAL COURT REGARDING PATENT INTERFERENCE PROCEEDINGS WITH SIENNA BIOPHARMACEUTICALS INC

Select another date: